| Stock |
Weight |
Amount |
| Johnson & Johnson |
12.42% |
$30,242,604 |
| Pfizer |
10.72% |
$26,086,485 |
| Novartis Ag-adr |
8.89% |
$21,651,822 |
| Merck & Co. |
7.21% |
$17,548,221 |
| Sanofi-adr |
6.34% |
$15,443,445 |
| Glaxosmithkline Plc-spon Adr |
6.15% |
$14,978,164 |
| Abbvie |
5.20% |
$12,647,640 |
| Bristol-myer Sqb |
5.06% |
$12,317,425 |
| Astrazeneca Plc-spons Adr |
4.76% |
$11,591,647 |
| Abbott Laboratories |
4.62% |
$11,234,374 |
| Eli Lilly & Co. |
4.21% |
$10,250,020 |
| Teva Pharmaceutical-sp Adr |
4.20% |
$10,234,280 |
| Novo-nordisk A/S-SPONS Adr |
4.02% |
$9,787,553 |
| Allergan |
3.69% |
$8,983,605 |
| Valeant Pharmaceuticals Inte |
2.79% |
$6,797,541 |
| Shire Plc-adr |
2.37% |
$5,766,321 |
| Actavis |
2.16% |
$5,249,916 |
| Mylan |
1.64% |
$3,987,302 |
| Perrigo Co. |
1.38% |
$3,369,082 |
| Forest Laboratories |
1.17% |
$2,851,794 |
| Page 1 2 next » |
|
